• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Familial hypercholesterolaemia: Walking time bombs and digging for gold

    Thumbnail
    View/Open
    58350_1.pdf (452.2Kb)
    Author(s)
    Hamilton-Craig, I
    Griffith University Author(s)
    Hamilton-Craig, Ian
    Year published
    2008
    Metadata
    Show full item record
    Abstract
    Most GPs will have in their practice patients with heterozygous FH, whether recognised or not. Most adults with FH are diagnosed sporadically. FH in children remains largely undiagnosed and untreated. Coronary atherosclerosis in adult patients with FH can be controlled with effective LDL-C lowering, but this requires maximum doses of potent statins in combination with ezetimibe, and often resins and nicotinic acid as well. Referral of patients with FH to a lipid clinic with experience in this area is the preferred option for family screening, a key component of FH management. Ongoing management of patients with FH should be ...
    View more >
    Most GPs will have in their practice patients with heterozygous FH, whether recognised or not. Most adults with FH are diagnosed sporadically. FH in children remains largely undiagnosed and untreated. Coronary atherosclerosis in adult patients with FH can be controlled with effective LDL-C lowering, but this requires maximum doses of potent statins in combination with ezetimibe, and often resins and nicotinic acid as well. Referral of patients with FH to a lipid clinic with experience in this area is the preferred option for family screening, a key component of FH management. Ongoing management of patients with FH should be undertaken jointly by GPs and the lipid clinic. There is a need for improved health professional and community awareness of FH as a serious and relatively common genetic disorder for which effective treatments are available.
    View less >
    Journal Title
    Medicine Today
    Volume
    9
    Issue
    1
    Publisher URI
    http://www.medicinetoday.com.au/
    Copyright Statement
    © 2008 Medicine Today Pty. Ltd. Reproduced in accordance with the copyright policy of the publisher. Use hypertext link for access to the publisher's website.
    Subject
    Biomedical and clinical sciences
    Publication URI
    http://hdl.handle.net/10072/26834
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander